Beyond the hospital: payment and access matter too
Insurance plans, trial announcements and global licensing each need their own evidence.
Three things to know
Cambodia’s AZ Group described a proposed insurance-linked pathway. The insurer, hospitals, coverage terms and launch date were not disclosed; an operating program was not established.
Akeso announced positive preliminary trial results. Full data and approval for the specific indication are separate questions, as is international-patient access.
The briefing also discusses overseas licensing. If a treatment becomes approved and supplied closer to home, the reason to travel may change.
This is a dated video briefing. Reports and availability may have changed since it was recorded; confirm current details before making plans.
The original post is labeled 0826; the video’s opening and captions date this briefing to 27 August 2026. This article follows the video.